
|Articles|October 1, 2016
Threats to Truvada Efficacy in HIV Protection
At the 25th European Academy of Dermatology and Venereology Congress in Vienna, Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health, discussed the importance of persistence in Truvada use for HIV pre-exposure prophylaxis.
Advertisement
At the 25th European Academy of Dermatology and Venereology Congress in Vienna, Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health, discussed the importance of persistence in Truvada use for HIV pre-exposure prophylaxis.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
2
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
3
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
4
Study Reveals a Widening Gap Between Buprenorphine Prescribing and Dispensing
5



































































































